CNR2 and cancer: CB2 [1,2,3,4] is mainly associated with immune suppression, apoptosis and cell migration and thus gradually becoming a therapeutic target for immunomodulation, inflammatory and neuropathic pain, neurodegenerative disorders, neuroinflammation, fibrotic condition and cancer.